OClawVPS.com
Deep Forest Sciences
Edit

Deep Forest Sciences

https://deepforestsci.com/
Last activity: 19.12.2022
Active
Categories: Artificial IntelligenceFashionHealthTechLearnNoCodeProductScienceServiceSoftwareTools
Deep Forest Sciences is working to make cutting edge AI/ML tools for drug discovery accessible to scientists in the biotech/pharma industry. Many of the world’s best biologists and chemists are not software engineers and machine learning experts. Deep Forest Science wants to help these scientists leverage modern AI tools to extend and sharpen their keen scientific insight so that we can bring more innovative medicine to patients. Our product, Chiron, enables scientists to run cutting-edge AI tools without having to code. In particular, Chiron provides access to pretrained scientific foundation models which allow scientists to use AI tools with limited experimental data.
Many of the world’s best biologists and chemists are not software engineers and machine learning experts. Deep Forest Science wants to help these scientists leverage modern AI tools to extend and sharpen their keen scientific insight so that we can bring more innovative medicine to patients. Our product, Chiron, provides a modern UI that enables scientists to run cutting-edge AI workflows in a no-code fashion. We also offer white-glove services to build custom workflows and pipelines for companies to onboard and process their existing datasets on top of the Chiron platform.
Our product, Chiron, provides a modern UI that enables biologists and chemists to run cutting-edge AI workflows in a no-code fashion. We provide access to out-of-the-box pretrained scientific foundation models to bring value to teams from day 1, and also provide a programmatic python API for power users. Our team offers white-glove services to help our partners leverage these tools and customize them for their internal use cases.
Website visits
3.3K /mo.
Mentions
1

Investors 2

Mentions in press and media 1

DateTitleDescription
19.12.2022Merck Digital Sciences Studio Announces the Launch of its First CohortNEWARK, N.J. (PRWEB) December 19, 2022 On Friday December 16, Merck (NYSE: MRK) today announced the launch of their first biopharmaceutical cohort through the Merck Digital Sciences Studio (MDSS), a collaboration between Merck, Microsoft fo...

Reviews 0

Sign up to leave a review

Sign up Log In